Immunic Financial News

24.12 / 04:26
Immunic vaccine Virus SARS-CoV-2 cover infection strain JN.1 Covid strain: Do we need a new vaccine? Ex-AIIMS chief Dr Randeep Guleria, ‘Need a new jab that…’
ANI, “It is more transmissible, it is spreading more rapidly, and it is gradually becoming a dominant variant. It is causing more infections but the data also suggests that it is not causing severe infections or hospitalisations.
23.12 / 13:32
Immunic hospital testing patient infection symptoms Study finds evidence of brain injury present even months after acute Covid infection
brain injury developed due to COVID-19 were found in patients even months after the infection and despite blood tests measuring inflammation returning normal results, according to a new research. Researchers from universities in the UK explained that during the acute phase of the viral infection, when symptoms develop quickly, key inflammatory proteins and brain injury markers are produced.
23.12 / 04:01
Fighting Strategy Immunic President 2020 reports US Supreme Court rejects Jack Smith's request to fast-track Donald Trump's immunity case
Donald Trump has any immunity from federal prosecution for alleged crimes he committed while in office, CNN reported. The court did not explain its reasoning and there were no noted dissents.
23.12 / 01:14
Provident Immunic President Divinity track social 2020 Supreme Court rejects to put Donald Trump's immunity case on fast track
Also Read: Donald Trump disqualified from Colorado's presidential primary ballot | What it means for 2024 US elections? The Supreme Court, which has a 6-3 conservative majority, including three justices nominated by Trump, denied the request in a one-line order that did not provide any reason for the decision. The 77-year-old, the frontrunner for the 2024 Republican presidential nomination, is currently scheduled to go on trial on March 4, 2024 on charges of conspiring to overturn the November 2020 election won by Democrat Joe Biden.
22.12 / 16:00
Target Extreme Immunic track reports shock Govt clarifies position on debt, says general govt debt will decline substantially in the medium to long term
debt could be 100% of GDP by FY28, stating that centre and states were on path of consolidation and the general govt debt is expected to decline substantially in the medium- to long-term. The government noted that the IMF staff report had presented the figures as a worst-case scenario and was not a ‘fait accompli’. “It is also noteworthy that the same report indicates that under favourable circumstances, the General Government Debt to GDP ratio may decline to below 70 per cent in the same period.
22.12 / 08:47
Immunic vaccine pandemic Virus testing infection symptoms NOT Covid is back: Cause for concern, but not for panic
A sub-variant of the all-too-familiar Omicron, dubbed JN.1, is the villain this time around. India has experience combating mass covid infections, unlike when the pandemic hit us in 2020. Hospitals are better equipped with oxygen, ventilators and medical staff who know what to do in the face of a covid surge.
21.12 / 23:17
Matthews Immunic Ozon reports Department Supreme Court will hear challenge to EPA rule limiting downwind power plant pollution in 10 states
The Supreme Court will hear arguments in February on whether the Environmental Protection Agency can continue enforcing its anti-air-pollution “good neighbor” rule in 10 states
21.12 / 10:53
Death Immunic Bill New criminal laws give doctors immunity against medical negligence: Read details here
MPs who have been suspended for "misconduct" for the remainder of the winter session. The Opposition has been demanding a statement from Union Home Minister Amit Shah on the December 13 Parliament security breach.
21.12 / 04:41
Immunic vaccine Experts show infection strain Vaccines Covid-19 cases rise in India: Existing vaccines protect against JN.1 sub-variant? What expert says
JN.1 is a descendant of the "pirola" variant BA 2.86, which by itself is an Omicron subvariant. JN.1 has an additional mutation receptor binding domain (L455S) compared to BA 2.86. JN.1 has extensive resistance across receptor binding domain classes 1, 2, and 3 and shows higher immune evasion as compared with BA 2.86 and other resistant strains.
21.12 / 02:52
Immunic Virus SARS-CoV-2 track guidelines strain Updates New covid variant JN.1: India logs 21 cases; Know mask guidelines, other details | 10 updates
Covid is spiking again. Just how serious is it now? JN.1 Covid variant: 21 cases found in India, highest detected in THIS state Covid’s new strain JN.1 not a cause for immediate concern: Centre COVID-19: Mumbai leads with 8 out of 11 Maharashtra cases; virus tracking sought JN.1 (BA.2.86.1.1) variant emerged in late 2023 and is a descendant of the BA.2.86 lineage (Pirola) of SARS-CoV-2.
21.12 / 02:39
Immunic SARS-CoV-2 country hospital reports symptoms India on alert as 21 new cases of JN.1 Covid subvariant reported: Here's what doctors advise
JN.1 subvariant of COVID-19, India is on high alert. This new variant, part of the Omicron family, has spurred a focused response from health authorities as 21 cases have been reported across the country. The World Health Organization has labeled JN.1 as a «variant of interest,» prompting a closer examination of its impact. The JN.1 variant, a descendant of the BA.2.86 lineage of SARS-CoV-2, is distinct from the Omicron XBB lineages.
20.12 / 07:43
Citi Platform Highways Immunic pandemic shock Mumbai Welspun One to invest Rs 700 crore to develop 1.2-million-sq-ft logistic hub in Navi Mumbai
Welspun One, an integrated fund and development management platform, will be investing over Rs 700 crore to develop an industrial and logistics hub spread across 55 acres within the Jawaharlal Nehru Port Authority (JNPA) Special Economic Zone (SEZ) in Navi Mumbai. For this, Welspun One has entered into a strategic collaboration with JNPA to jointly develop this project. The investment includes both land as well as construction cost. This marks the second deployment from Welspun Ones’ latest alternative investment fund that has a total corpus of Rs 2,000 crore.
19.12 / 13:39
Immunic vaccine Virus reports infection symptoms Mint Explainer: Everything you need to know about the latest Covid variant
Mint explains what the new virus is, its symptoms and efficacy of the vaccine: The new variant, experts have warned, appears to be more immune evasive and has been identified by WHO scientists as a ‘variant of interest’. JN.1 was first detected in the US in September 2023. By the end of October, it made up less than 0.1% of SARS-CoV-2 viruses, as per US Centers for Disease Control and Prevention (CDC).
19.12 / 09:38
Provident Platform Action Immunic Actor stage information Retik Finance (RETIK): A Complete Guide
https://retik.com. This official platform is carefully designed to ensure the security and transparency of the token sale process, protecting the interests of investors and the project's integrity. By acquiring RETIK tokens during presale, you become an early supporter of Retik Finance, which can offer unique advantages as the project evolves.
19.12 / 05:20
Invesco WhatsApp Immunic Experts show stars recommendations MFs increased bets on these 8 smallcap stocks that gave over 40% returns in 1 month
market as the gauge for smallcap stocks has given about 15% returns. With smallcap stocks continuing their non-stop one-way move, mutual funds increased their bets in many of them in the last one month. Atleast eight small cap stocks, which have given more than 40% returns since November, saw increase in mutual fund holding, data by Ace MF showed.
19.12 / 05:19
Waters Nov Immunic hospital outbreak Department infection Here's what you need to know about the deadly salmonella outbreak tied to cantaloupes
A deadly outbreak of salmonella poisoning linked to contaminated whole and pre-cut cantaloupe continues to grow
18.12 / 19:13
Ball Immunic Experts testing Department sanitizer ventilators Here we Covid again, this time feeling se
Covid cases are on the rise again. Singapore has issued a health advisory as new cases climbed to some 56,000 in the December 3-9 week, up from some 32,000 the week earlier. Experts say there is no cause for worry.
18.12 / 16:51
Action Southern Immunic vaccine Virus infection Centre Centre issues Covid advisory to states with Omicron sub-variant on the rise
NEW DELHI : The Union government has advised all states to implement tighter public health measures to minimise transmission of the Covid-19 virus, following a rise in infections in some states, particularly Kerala. The first case of a new sub-variant of Covid-19, JN.1, was detected on 8 December in the southern state, raising concerns about a resurgent health risk more than two years after India’s last pandemic-related lockdown.
18.12 / 13:17
Immunic Experts prevention infection symptoms 7 health risks associated with vitamin D deficiency: Depression, brittle bones, poor heart health
sunshine vitamin’! Vitamin D is a fat-soluble nutrient that is essential for our health. It plays a key role in boosting our immunity as well as bone health. It also has a crucial role in preventing several chronic health issues such as type 2 diabetes, bone loss, compromised heart health, etc.
18.12 / 07:27
Immunic Virus country reports prevention symptoms Covid JN.1 virus arrives in India: What are the symptoms, precautions and should you worry?
coronavirus, named JN.1, has been detected in a woman from Kerala, raising concerns about the ongoing battle against Covid-19. The Indian government confirmed the presence of the JN.1 sub-variant on December 16, marking the first case of its kind in the country.

frequently asked questions about Immunic

What is Immunic and why is it important?

Immunic is a significant category that draws public attention. On our site, we regularly publish updates related to this subject.

Where can I find the latest updates on Immunic?

All new posts about Immunic can be found in the dedicated section. We publish information in a timely manner.

How can I verify the accuracy of information on Immunic?

We rely on trusted sources to ensure that the information about Immunic is reliable and helpful for our readers.